Excellent financial performance driven by the Group’s acceleration in high performance materials, and its agility in a complex global environment.

Due to strong demand for lithium-ion batteries and other important markets, Arkema’s previously announced 35% fluoropolymer capacity increase at its Changshu site in China is now revised upwards to a capacity increase of 50%.

This new production capacity will be part of Arkema’s previously announced major bio-factory currently under construction on Jurong Island in Singapore.